Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
News-Medical.Net on MSN
New clinical trial shows promise for shorter TB treatment
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
allAfrica.com on MSN
Africa: Phase 2 Clinical Trial Results Show Potential to Shorten TB Treatment Time
Sorfequiline, previously known as TBAJ-876, was evaluated in combination with pretomanid and linezolid in a randomized, controlled trial in people with drug-sensitive TB ...
Phase 2 trial shows sorfequiline with pretomanid and linezolid may enhance TB treatment efficacy and safety for drug-sensitive patients.
Despite strong national programmes, late diagnosis, treatment gaps, private-sector fragmentation, and poor adherence remain ...
Science Africa on MSN
TB Treatment Can be Shortened, Clinical Trial Shows
By Sharon Atieno With tuberculosis (TB) treatment lasting about six to nine months, a new treatment regimen is set to reduce this period.A phase two clinical trial by TB Alliance has showed that a new ...
An international team of investigators today announced promising data from a trial of a novel antibiotic that could ...
Statista on MSN
Drug-Resistant TB Slows Path to Global 90% Target
This chart shows the share of people diagnosed with tuberculosis (TB) who were cured/completed their treatment, by TB type (in %)*.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback